Russell C. Petter
Corporate Officer/Principal chez Avila Therapeutics, Inc.
Profil
Russell C.
Petter is the founder of Arrakis Therapeutics, Inc. founded in 2015, where he held the title of Chief Scientific Officer.
He is currently the Vice President-Drug Discovery at Avila Therapeutics, Inc. Dr. Petter's former positions include Principal at Biogen MA, Inc. and Biogen, Inc., Vice President-Research at Mersana Therapeutics, Inc., and Principal at Sandoz Research Institute.
Dr. Petter received his undergraduate degree from Dartmouth College in 1978 and his doctorate from Duke University in 1993.
Postes actifs de Russell C. Petter
| Sociétés | Poste | Début |
|---|---|---|
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Corporate Officer/Principal | 16/04/2009 |
Anciens postes connus de Russell C. Petter
| Sociétés | Poste | Fin |
|---|---|---|
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Fondateur | - |
| Sandoz Research Institute | Corporate Officer/Principal | - |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
| MERSANA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Russell C. Petter
| Dartmouth College | Undergraduate Degree |
| Duke University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
| Sandoz Research Institute | |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arrakis Therapeutics, Inc. operates as a biopharmaceutical company. It develops rna-targeted small molecule medicines focused on neurologic, cancer, and rare genetic diseases. The company was founded by Russell C. Petter, Alan E. Walts, Jennifer C. Petter and Raj Bhikhu Parekh in 2015 and is headquartered in Waltham, MA. | Health Technology |
